Fn14 Promotes Differentiation of Human Mesenchymal Stem Cells into Heart Valvular Interstitial Cells by Phenotypic Characterization. Issue 5 (May 2014)
- Record Type:
- Journal Article
- Title:
- Fn14 Promotes Differentiation of Human Mesenchymal Stem Cells into Heart Valvular Interstitial Cells by Phenotypic Characterization. Issue 5 (May 2014)
- Main Title:
- Fn14 Promotes Differentiation of Human Mesenchymal Stem Cells into Heart Valvular Interstitial Cells by Phenotypic Characterization
- Authors:
- Huang, Wei
Xiao, Ding‐Zhang
Wang, Yigang
Shan, Zhi‐Xin
Liu, Xiao‐Ying
Lin, Qiu‐Xiong
Yang, Min
Zhuang, Jian
Li, Yangxin
Yu, Xi‐Yong - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="jcp24480-sec-0001" sec-type="section"> <p>Despite the fact that tissue engineered heart valves (TEHV) hold great promise for heart valve disease treatment, one of the challenges is to find suitable seeding cells. Bone marrow derived mesenchymal stem cells (MSCs) were considered to be one of the best seed cell sources. In this study we propose a novel approach to promote stem cell differentiation into the seed cells of TEHV, valvular interstitial cells (VICs). Newly induced MSCs (iMSCs) were created from a co‐culture niche in which healthy human donor derived MSCs were co‐cultured with cardiac fibroblasts (H9C2 cell line). Then iMSCs were transfected with either a mock vector (iMSCs<sup>mock</sup>) as controls or with a vector that overexpresses thefibroblast inducible factor 14 (Fn14) gene (iMSCs<sup>Fn14</sup>). Immunofluorescence staining was performed to assay VIC differentiation. Western blot analysis was performed to analyze the involved signaling pathway. The results demonstrate that the expression of α‐smooth muscle actin (SMA) was significantly higher in iMSCs<sup>Fn14</sup> as compared with iMSC<sup>mock</sup>, and MSC, and also had higher co‐alignment of α‐actinin and stress fiber (F‐actin) in bundles. Additionally, increased biosynthesis of extracellular matrix (ECM) proteins including collagen I, collagen III, and fibronection were observed in iMSCs<sup>Fn14</sup> in<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="jcp24480-sec-0001" sec-type="section"> <p>Despite the fact that tissue engineered heart valves (TEHV) hold great promise for heart valve disease treatment, one of the challenges is to find suitable seeding cells. Bone marrow derived mesenchymal stem cells (MSCs) were considered to be one of the best seed cell sources. In this study we propose a novel approach to promote stem cell differentiation into the seed cells of TEHV, valvular interstitial cells (VICs). Newly induced MSCs (iMSCs) were created from a co‐culture niche in which healthy human donor derived MSCs were co‐cultured with cardiac fibroblasts (H9C2 cell line). Then iMSCs were transfected with either a mock vector (iMSCs<sup>mock</sup>) as controls or with a vector that overexpresses thefibroblast inducible factor 14 (Fn14) gene (iMSCs<sup>Fn14</sup>). Immunofluorescence staining was performed to assay VIC differentiation. Western blot analysis was performed to analyze the involved signaling pathway. The results demonstrate that the expression of α‐smooth muscle actin (SMA) was significantly higher in iMSCs<sup>Fn14</sup> as compared with iMSC<sup>mock</sup>, and MSC, and also had higher co‐alignment of α‐actinin and stress fiber (F‐actin) in bundles. Additionally, increased biosynthesis of extracellular matrix (ECM) proteins including collagen I, collagen III, and fibronection were observed in iMSCs<sup>Fn14</sup> in comparison with iMSCs<sup>mock</sup>. These data observed in iMSCs<sup>Fn14</sup> were in accordance with VIC phenotype from normal heart valves. In addition, the PI3K/Akt signaling pathway was activated in iMSCs<sup>Fn14</sup> which allowed higher Akt phosphorylation (p‐Akt) levels and SMA levels, whereas, it was attenuated by LY294002 (PI3K/Akt inhibitor). These new findings of the effect of Fn14 on VIC‐like cell differentiation may provide a novel therapeutic strategy for heart valve disease treatment. J. Cell. Physiol. 229: 580–587, 2014. © 2013 Wiley Periodicals, Inc.</p> </sec> </abstract> … (more)
- Is Part Of:
- Journal of cellular physiology. Volume 229:Issue 5(2014:May)
- Journal:
- Journal of cellular physiology
- Issue:
- Volume 229:Issue 5(2014:May)
- Issue Display:
- Volume 229, Issue 5 (2014)
- Year:
- 2014
- Volume:
- 229
- Issue:
- 5
- Issue Sort Value:
- 2014-0229-0005-0000
- Page Start:
- 580
- Page End:
- 587
- Publication Date:
- 2014-05
- Subjects:
- Physiology -- Periodicals
Cell physiology -- Periodicals
571.6 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-4652 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jcp.24480 ↗
- Languages:
- English
- ISSNs:
- 0021-9541
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.020000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3834.xml